Title | Sponsor | Award |
---|---|---|
Peer Review of PCORI's Funded Research |
Oregon Health and Science University |
$45,757 |
Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial |
Boston University |
$16,446 |
Biosynthetic studies and development of ribomimetic-based anti-infectives |
National Institutes of Health |
$357,955 |
EpiCenter - EPIdemiology of opioid prescribing in community health CENTERs |
Oregon Health and Science University |
$36,824 |
Oregon Clinical and Translational Research Institute KL2 Program |
Oregon Health and Science University |
$35,165 |
The Chemical Ecology and Group Dynamics of Modern Microbialite Communities |
Gordon and Betty Moore Foundation |
$299,487 |
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain |
Oregon Health and Science University |
$89,636 |
Nanoparticles based mRNA delivery for treatment of cystic fibrosis |
National Institutes of Health |
$658,627 |
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease |
National Institutes of Health |
$960,276 |
Reducing Overdose After Release from Incarceration (ROAR) |
Oregon Health and Science University |
$92,497 |
Improving access to care through pharmacist prescription of hormonal contraception |
Oregon Health and Science University |
$14000 |
Optimizing Antibiotic Prescribing on Discharge to Long-term Care Facilities |
Agency for Healthcare Research and Quality |
$547,351 |
Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands |
National Institutes of Health |
$388,638 |
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia |
National Institutes of Health |
$446,372 |
Validation of preclinical assays with clinical data to evaluate the safety of estrogenic botanical dietary supplements |
National Institutes of Health |
$41,443 |
Research Training in Natural Product Complementary and Integrative Health |
National Institutes of Health |
$248,169 |
Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia |
National Institutes of Health |
$614,464 |
A nanoparticle-based approach for surgical imaging and intraoperative treatment of endometriosis |
Oregon Health and Science University |
$103,023 |
Near Infrared Nerve-specific Fluorophores for Clinical Fluorescence Guided Surgery |
Oregon Health and Science University |
$12,632 |
Novel Materials for Gene Delivery to treat CF |
Cystic Fibrosis Foundation |
$267,433 |
Overcoming gene delivery barriers to the back of the eye |
National Institutes of Health |
$238,145 |
Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes |
University of Wisconsin |
$44,735 |
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) study |
Oregon Health and Science University |
$30,420 |
Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial |
Brandeis University |
$133,930 |
Metabolic response to traditional diets in Alaska Native people |
Oregon Health and Science University |
$74,375 |
Prescription Drug Monitoring Program Integration in the Electronic Health Record |
Agency for Healthcare Research and Quality |
$140,846 |
ApoE Isoform-Dependent Changes in Brain Bioenergetics Post-Menopause in Response to Xanthohumol |
Collins Medical Trust |
$30,000 |
IIR 17-039 Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids |
Oregon Dept. of Veterans' Affairs |
$19,373 |
Collaborative Research: CompCog:Psychological, computational, and neural adequacy in a deep learning model of human speech recognition |
National Science Foundation |
$178,934 |
Small Molecule screen for inhibition of SARS-CoV-2 |
ReSeptr Therapeutics, LLC |
$21,650 |
Dual anti-CD47 and Duramycin Functionalized Carriers for Radio-enhanced Drug Delivery |
PhRMA Foundation |
$25,000 |
Flip the Pharmacy (FtP) PracNce TransformaNon Team (PTT) |
GPP Solutions, LLC |
$6,250 |
Lipid Nanoparticle Delivery of Saliogase EDIT Technology |
SalioGen Therapeutics |
$99,178 |
Nanoparticle mediated delivery of modified CFTR mRNA for treatment of cystic fibrosis |
Cystic Fibrosis Foundation |
$63,350 |
Microbiota, Tertiary Lymphoid Structures and Chronic Inflammation in the Human Gut |
University of Massachusettes |
$111,375 |
Understanding the impact of radiation on endocytosis of small molecule therapies and their nanoformulations |
American Foundation for Pharmaceutical Education |
$5,000 |
Role of Non-calcemic vitamin D-hydroxyderivatives as preventive agents in melanoma |
Oregon Health and Science University |
$50,000 |
New technologies for inhalable nanoparticles |
Rare Air Health, LLC |
$31,733 |
Prepare CPD100Li formulation |
Cascade ProDrug Inc | $92,152 |
Lipid nanoparticles for gene editing |
Beam Therapeutics |
$390,932 |